Related Experiment Videos
Deoxycoformycin toxicity in mice after long-term treatment
Cancer Chemotherapy and Pharmacology
|January 1, 1980
Summary
Deoxycoformycin, an adenosine deaminase inhibitor, impacts mouse tissues, affecting enzyme recovery rates differently across organs. These variations in deoxycoformycin enzyme inhibition and recovery suggest varied cell proliferation and protein synthesis roles.
Area of Science:
- Pharmacology
- Biochemistry
- Immunology
Background:
- Deoxycoformycin is a potent lymphocytotoxic agent and a tight-binding inhibitor of adenosine deaminase.
- Adenosine deaminase plays a crucial role in lymphocyte proliferation and immune function.
Purpose of the Study:
- To investigate the effects of deoxycoformycin on various mouse tissues.
- To analyze the dose-dependent inhibition and tissue-specific recovery of adenosine deaminase following deoxycoformycin administration.
Main Methods:
- Mice were administered deoxycoformycin via intraperitoneal injection at single or repeated doses (0.2 or 10.0 mg/kg).
- Adenosine deaminase activity was measured in liver, blood, jejunum, spleen, kidney, and lungs.
- Enzyme recovery rates were monitored over a 28-day period.
Main Results:
- Repeated high-dose deoxycoformycin caused growth retardation and increased lung/splenic mass, without altering body temperature, hematocrit, or total leukocyte count.
- Complete adenosine deaminase inhibition was observed in all tissues at the higher dose, with dose-dependent inhibition in some tissues at lower doses.
- Enzyme recovery varied significantly by tissue, with rapid recovery in the jejunum and slower recovery in the spleen and liver.
Conclusions:
- Tissue-specific differences in adenosine deaminase recovery after deoxycoformycin treatment were observed.
- Recovery rates appear to correlate with cell proliferation and protein synthesis rates.
- These variations may influence the pharmacological and chemotherapeutic applications of deoxycoformycin.